← Back to Search

Behavioral Intervention

Brain Health Education Arm for Healthy Subjects

N/A
Waitlist Available
Led By Mark McInnis, BA
Research Sponsored by Retain Health, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
be at least 53 years of age
have a family history of Alzheimer's Disease (AD)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months and 6 months.
Awards & highlights

Study Summary

This trial will test if a cell phone-based online program can help reduce Alzheimer's risk and improve memory through digital education and tracking.

Who is the study for?
This trial is for individuals aged 53 or older with a family history of Alzheimer's Disease. Participants must have a compatible phone or tablet, and at least one risk factor such as being overweight, having pre-diabetes/diabetes, high blood pressure/cholesterol, smoking habits, low physical activity/fish intake, high alcohol consumption or mild/moderate depression.Check my eligibility
What is being tested?
The study tests an online program on RetainYourBrain.com that assesses Alzheimer's risk and memory through digital education and cognitive games over six months. It aims to see if this approach can improve brain health and reduce the risk of developing Alzheimer's disease.See study design
What are the potential side effects?
Since the intervention involves educational content and cognitive testing via a cell phone-based program rather than medication or medical procedures, there are no direct side effects associated with traditional clinical trials.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 53 years old or older.
Select...
My family has a history of Alzheimer's Disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months and 6 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months and 6 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Australian National University Alzheimer's Disease Risk Index (ANU-ADRI)
Secondary outcome measures
Cogstate Brief Battery
Fear of Alzheimer's Disease Scale
Other outcome measures
Costs or savings associated with using the online software application
User Satisfaction

Trial Design

2Treatment groups
Experimental Treatment
Group I: Brain Health Education ArmExperimental Treatment1 Intervention
Subjects will receive an Alzheimer's risk assessment, memory testing, and brain health education, in addition to text message communication.
Group II: Alzheimer Disease Education ArmExperimental Treatment1 Intervention
Subjects will receive an Alzheimer's risk assessment, memory testing, and general education about Alzheimer's disease, in addition to text message communication.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brain Health Education
2020
N/A
~150

Find a Location

Who is running the clinical trial?

Retain Health, IncLead Sponsor
National Institute on Aging (NIA)NIH
1,673 Previous Clinical Trials
28,020,103 Total Patients Enrolled
University of CincinnatiOTHER
428 Previous Clinical Trials
633,658 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this study only consider persons below a certain age for inclusion?

"As per this trial's inclusion requirements, the minimum and maximum age of enrolment are 53 and 105 respectively."

Answered by AI

How many people can participate in this experiment at one time?

"Affirmative. Clinicaltrials.gov data demonstrates that this clinical trial, inaugurated on December 7th 2023, is actively recruiting participants. To fulfill the requirements of the research project, 736 individuals must be enrolled from a single medical site."

Answered by AI

Is there an ongoing recruitment process for this experiment?

"Affirmative. Clinicaltrials.gov provides evidence that this medical study, originally posted on December 7th 2023, is actively seeking participants. Specifically, they require the recruitment of 736 patients from a single site."

Answered by AI

What qualifiers must be met for an individual to participate in this clinical research?

"This trial is seeking 736 individuals between the ages of 53 and 105 who are in generally good health. Additionally, applicants must be at least 53 years old, possess a family background with Alzheimer's disease (AD), have access to a technological device which allows text messaging and internet usage or similarly capable tablet device, as well as display any one of these determinants: BMI above 25 history of pre-diabetes/diabetes hypertension hypercholesterolemia smoking low physical activity rate lower than two times per week reduced fish intake rate underneath 3 periods monthly elevated alcohol consumption surpassing seven servings weekly for female patients and fourteen servings each week for male"

Answered by AI

Who else is applying?

What site did they apply to?
Retain Health, Inc.
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I am interested in advancing medical science.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
The Retain Your Brain Health Study (RetainYourBrain.Com)
2023. "The Retain Your Brain Health Study (RetainYourBrain.Com)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06027320.
All > Alzheimers Disease Boston
~327 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top